SCHEMBL3938451

SCHEMBL3938451

O=C(O)NCCC1CCN(Cc2cccc(Oc3ccc(F)cc3)c2)CC1

nearest known ligand 0.65

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 10/20 0.65
CCR8 P51685 4/20 0.56
BCHE P06276 1/20 0.56
ACHE P22303 1/20 0.56
CCR3 P51677 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3599975 0.90 CCR8 (0.58) CHRM4CCR8BCHEACHECCR3
SCHEMBL2967113 0.85 CHRM4 (0.54) CHRM4CCR8BCHEACHE
SCHEMBL3946316 0.85 CHRM4 (0.69) CHRM4
SCHEMBL3591109 0.83 CCR8 (0.71) CCR8CCR3
SCHEMBL3940943 0.82 CHRM4 (0.57) CHRM4BCHEACHE
SCHEMBL3937764 0.82 CHRM4 (0.57) CHRM4ACHE
SCHEMBL27654951 0.79 CHRM4 (0.50) CHRM4CCR8
SCHEMBL3938442 0.79 CHRM4 (0.66) CHRM4ACHE
SCHEMBL6500525 0.79 CCR8 (0.88) CCR8CCR3
SCHEMBL18825716 0.78 CHRM4 (1.00) CHRM4ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720550-B1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2009-04-15 EP claimed
EP-1720550-B1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2009-04-15 EP disclosed
EP-1720550-A1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS Sanofi-Aventis (FR) 2006-11-15 EP disclosed
WO-2005089759-A1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2005-09-29 WO disclosed